Fresenius sells biotechnology business
Fresenius Biotech develops and markets biopharma-ceuticals for the effective treatment of severe diseases. ...
ATG Fresenius® S
, a polyclonal antibody, is successfully marketed in over 60 countries. ...
We develop and market innovative antibody therapies for the treatment of cancer. We recently launched
, a trifunctional antibody indicated for the treatment of malignant ascites. ...
© 29.07.2009 Fresenius Biotech GmbH